Skip to main content
Novartis
language-selector-globe
Choose Location
  • International
  • Americas
  • Asia Pacific
  • Europe
  • Middle East & Africa
Global | English(link is external)
Novartis Foundation | English(link is external)
Argentina | Español(link is external)
Brazil | Português(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Mexico | Español(link is external)
United States | English(link is external)
Australia | English(link is external)
Bangladesh | English(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
India | English(link is external)
Indonesia | English(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Singapore | English(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Austria | Deutsch(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Bulgaria | Български(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hungary | Magyar(link is external)
Ireland | English(link is external)
Italy | Italiano(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Serbia | Srpski(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
Egypt | English(link is external)
Israel | עברית(link is external)
Saudi Arabia | العربية(link is external)
South Africa | English(link is external)
language-selector-globe
Choose Location
International Americas Asia Pacific Europe Middle East & Africa
Argentina | Español(link is external)
Australia | English(link is external)
Austria | Deutsch(link is external)
Bangladesh | English(link is external)
Belgium | Français(link is external)
Belgium | Nederlands(link is external)
Brazil | Português(link is external)
Bulgaria | Български(link is external)
Canada | English(link is external)
Canada | Français(link is external)
Central America | Español(link is external)
Colombia | Español(link is external)
Czech Republic | Česky(link is external)
Czech Republic | English(link is external)
Denmark | Dansk(link is external)
Egypt | English(link is external)
Estonia | Eesti(link is external)
Finland | Suomalainen(link is external)
France | Français(link is external)
Germany | Deutsch(link is external)
Greece | Ελληνικά(link is external)
Hong Kong S.A.R. | 繁體中文(link is external)
Hungary | Magyar(link is external)
India | English(link is external)
Indonesia | English(link is external)
Ireland | English(link is external)
Israel | עברית(link is external)
Italy | Italiano(link is external)
Japan | 日本語(link is external)
Korea | 한국어(link is external)
Latvia | Latvian(link is external)
Lithuania | Lithuanian(link is external)
Mainland China | 中文(link is external)
Malaysia | English(link is external)
Mexico | Español(link is external)
Netherlands | Nederlands(link is external)
Norway | Norsk(link is external)
Global | English(link is external)
Novartis Foundation | English(link is external)
Pakistan | English(link is external)
Philippines | English(link is external)
Poland | Polski(link is external)
Portugal | Português(link is external)
Romania | Română(link is external)
Russia | Русский(link is external)
Saudi Arabia | العربية(link is external)
Serbia | Srpski(link is external)
Singapore | English(link is external)
Slovakia | Slovensky(link is external)
Slovenia | Slovenščina(link is external)
Slovenia | English(link is external)
South Africa | English(link is external)
Spain | Español(link is external)
Sweden | Svenska(link is external)
Switzerland | Deutsch(link is external)
Switzerland | Français(link is external)
Taiwan | 繁體中文(link is external)
Thailand | ภาษาไทย(link is external)
Türkiye | Türkçe(link is external)
United Kingdom | English(link is external)
United States | English(link is external)
    • About 

      • Board of Directors 

        • Giovanni Caforio 
        • Simon Moroney 
        • Ton Buechner 
        • Patrice Bula 
        • Elizabeth (Liz) Doherty 
        • Ana de Pro Gonzalo 
        • Bridgette Heller 
        • Daniel Hochstrasser 
        • Frans van Houten 
        • Elizabeth McNally 
        • John D. Young 
        • Charlotte Pamer-Wieser 
      • Executive Committee 

        • Vasant (Vas) Narasimhan 
        • Shreeram Aradhye 
        • Victor Bulto 
        • Aharon (Ronny) Gal 
        • Karen L. Hale 
        • Patrick Horber 
        • Harry Kirsch 
        • Rob Kowalski 
        • Steffen Lang 
        • Fiona Marshall 
        • Lutz Hegemann 
        • Kees Roks 
        • Michelle Weese 
      • Products 
      • Therapeutic areas 

        • Cardiovascular, renal and metabolic 
        • Immunology 
        • Neuroscience 
        • Oncology 
      • People and culture 
      • Inclusion 

        • Promoting inclusion 
        • Building belonging 
        • Parental leave 
      • Novartis Gene Therapies 
      • Manufacturing 
      • Quality 

        • Audit program 
        • Novartis quality management system (QMS) 
        • Product and patient safety training 
        • Regulatory inspections 
        • Product recalls 
        • Third-party suppliers 
      • Novartis and the European Union (EU) 
      • Awards and recognition 
      Mother and daughter cuddling on a bed in a kids room

      About

      Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

    • Patients and caregivers 

      • Novartis commitment to patients and caregivers 
      • Diseases 
      • Patient organization funding 
      • Patients perspectives stories 
      Adult daughter talking to her senior parents on a bench in a park

      Patients and caregivers

      Information for patients and their caregivers including clinical trial recruiting, managed access programs, funding opportunities for patient organizations and side effects reporting.

    • Healthcare professionals 

      • Medical congresses and events 

        • ASCO Annual Meeting 
      • Products 
      • Novartis pipeline 
      • Managed access programs 

        • Zolgensma® Global Managed Access Program (gMAP) 
      • Novartis external funding 
      • Healthcare professional resources by country 
      • Investigator-initiated trials / studies 
      • Novartis medical information 

        • Submit medical enquiry 
      Doctor discussing illness with patient in an office

      Healthcare professionals

      Resources for physicians and other healthcare professionals including clinical trial recruiting, grant funding, congresses and country-level information.

    • Research and development 

      • Technology platforms 
      • Research disease areas 

        • Cardiovascular and metabolic disease research at Novartis 
        • DAx: exploratory disease research at Novartis 
        • Global Health disease area research at Novartis 
        • Immunology disease research at Novartis 
        • Neuroscience research at Novartis 
        • Oncology research at Novartis 
      • Novartis pipeline 
      • Research collaborations 
      • Collaborations 
      A female research scientist in a lab looking at a sample

      Research & development

      Discover how Novartis turns breakthrough science into transformative, high-value treatments.
       

    • ESG 

      • Access 

        • Creating sustainable business models 
        • Value-based pricing 
        • Sub-Saharan Africa 
        • Donations 
        • Novartis access principles 
        • Novartis oncology access 
        • Patents and licensing 
      • Environmental sustainability 

        • Climate 
        • Nature - Waste 
        • Nature - Water 
      • Ethics, risk and compliance 

        • Ethical behavior 
        • Compliance 
        • Human rights 
        • Learning and engagement 
        • Integrated risk assurance 
      • Global health 

        • Pandemic preparedness 
        • Avoidable blindness 
        • Chagas disease 
        • Leprosy 
        • Malaria 
        • Sickle cell disease (SCD) 
        • Novartis Foundation  (link is external)
      • Inclusion 
      • ESG index 
      • Reporting and transparency hub 

        • ESG rating performance 
        • Targets 
        • Patient organization funding 
        • Payments to healthcare professionals 
        • Public policy 
        • A living wage 
        • A safe workplace 
        • Animal research 
      Family and friends having a party at home

      Environmental, social and governance

      Learn about our commitments to making a positive impact on the world by providing access to innovative medicines, protecting the environment, and upholding high ethical standards. Explore the Novartis in Society Integrated Report.

    • Investors 

      • Event calendar 
      • Financial data 

        • Novartis annual results 
        • Novartis quarterly results 
        • Novartis SEC filings 
        • Product sales 
        • Fixed-income securities 
        • Expected currency impact 
      • Share data and analysis 

        • Share monitor 
        • Dividend information 
        • Share ownership 
        • Share overview 
        • Return on investment calculator 
      • Shareholder information 

        • General Meetings 
        • American Depositary Receipts (ADR) 
        • Share buyback 
        • Frequently asked questions 
      • Company overview 

        • Corporate governance 
      • Reporting and transparency hub 

        • Reporting archive 
        • ESG rating performance 
        • Publications order form 
      • ESG 
      Business woman working on her laptop in a bright atmosphere

      Investors

      Updates and resources for investors including financial information, disclosures, events, share price, ESG and reporting.

    • News 

      • News archive  
      • Media library  
      • Stories 
      • Subscribe 
      • Events 
      Overhead view of a meeting room with people in the foreground and screens in the background

      News

      Information for journalists including media releases, statements, stories, multimedia resources and more.

    • Careers 

      • Career search 
      • Our business functions 

        • Careers in research and development 
        • Careers in operations 
        • Careers in commercial and sales 
        • Careers in global functions 
      • Why Novartis 
      • Career hub 

        • Temporary contracts  (link is external)
      • Early careers 

        • Graduates 
        • Students 
        • US Biomedical Research internship programs 
        • Community exploration and learning lab (CELL) 
      Two business people

      Careers

      Novartis is hiring! Find open positions, learn more about our strategy and culture, and apply today.

    • Clinical trials 
    • Partnering 
    • Supplier portal 
    • Report side effects 
    • Contacts 
    Grandmother, mother and daughter smiling and laughing on a beach

    Home

    Working together, we can reimagine medicine to improve and extend people’s lives.

  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Global Financial Controls and Compliance (FCC) Process Expert – Source to Pay (S2P), T&E (Travel and Expenses) and PRO (Procurement) Home Worker United Kingdom Finance CTS Audit & Finance May 19, 2025
Digital Finance-Manager Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 19, 2025
Digital Finance, Manager (Analytics Operations) Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 19, 2025
Global Finance Master Data Specialist Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance May 19, 2025
FRA Analyst Treasury and Cash Management (m/f/d) / Analitik - specialist (m/ž/d) Ljubljana Slovenia Finance Universal Hierarchy Node Audit & Finance May 19, 2025
BPA Manager Telangana India Finance Universal Hierarchy Node Audit & Finance May 18, 2025
TCM Payment Specialist Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance May 15, 2025
Manager - Corporate BPA Basel (City) Switzerland Finance Corporate Audit & Finance May 15, 2025
Business Planning & Analysis Manager Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia Finance Innovative Medicines Audit & Finance May 15, 2025
Specialist R2R Intercompany Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 14, 2025
Senior EBA Specialist Prague Czech Republic Finance CTS Audit & Finance May 14, 2025
Manager - IMI BPA Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 14, 2025
R2R Lead - 18 meses Sintra Portugal Finance CTS Audit & Finance May 13, 2025
Senior Financial Analyst Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 12, 2025
Record to Report Sr Specialist US INSURGENTES Mexico Finance CTS Audit & Finance May 07, 2025
Senior Specialist - Management Reporting INSURGENTES Mexico Finance CTS Audit & Finance May 07, 2025
Vodja računovodstva (m/ž/d) / Record to Report (R2R) Lead (m/f/d) Ljubljana Slovenia Finance Universal Hierarchy Node Audit & Finance May 06, 2025
Tax Manager Makati City Philippines Finance Universal Hierarchy Node Audit & Finance May 01, 2025
R2R Senior Specialist - Inventory Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Apr 21, 2025
Executive Director, Government Healthcare Administration East Hanover USA Finance Innovative Medicines Audit & Finance Apr 21, 2025
R2R GL Team Lead Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Apr 17, 2025
R2R Associate Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Apr 16, 2025
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Apr 15, 2025
Associate Director, General Management & Strategy Business Planning & Analysis (2 Positions) East Hanover USA Finance Innovative Medicines Audit & Finance Apr 15, 2025
P2P & T&E Ops Specialist (French Speaker) Selangor Malaysia Finance CTS Audit & Finance Apr 10, 2025
Senior Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Apr 10, 2025
Director, BD&L Finance East Hanover USA Strategy & Growth Corporate Audit & Finance Mar 31, 2025
FRA Head Baltics Latvia Latvia Finance Innovative Medicines Audit & Finance Mar 19, 2025
FC&C Manager Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Mar 19, 2025
Senior Manager, BPA Operations Toranomon (NPKK Head Office) Japan Finance Universal Hierarchy Node Audit & Finance Mar 19, 2025
Davčni manager (m/ž/d) / Tax Manager (m/f/d) Ljubljana Slovenia Finance Corporate Audit & Finance Mar 18, 2025
Analitik v oddelku Računovodstvo kupcev (m/ž) / FRA Analyst in Order to Cash department (m/f) Ljubljana Slovenia Finance Universal Hierarchy Node Audit & Finance Feb 20, 2025
R2R Specialist - GL & Reporting Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Feb 20, 2025
R2R Senior Specialist - Statutory Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Feb 04, 2025
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Jan 27, 2025
FRA Analyst Kyiv Ukraine Finance CTS Audit & Finance Jan 16, 2025
R2R Specialist - GL & Reporting Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Jan 10, 2025
Assistant Manager SOD Ops Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance Dec 19, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Nov 19, 2024
Chief Financial Officer - Manufacturing - Targu Mures Targu Mures Romania Operations Universal Hierarchy Node Audit & Finance Nov 18, 2024
Tax Team Lead Warsaw Poland Finance CTS Audit & Finance Nov 11, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Oct 15, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 09, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Oct 08, 2024
S2P Business Partner Selangor Malaysia Finance CTS Audit & Finance Sep 24, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Sep 23, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance Sep 17, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Sep 05, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations Universal Hierarchy Node Audit & Finance Aug 22, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • › Next page

Novartis

Working together
  • Patients and caregivers
  • Healthcare professionals
  • Researchers
  • Job seekers
  • Journalists
  • Investors
Topics
  • Q1 2025
  • Eurovision
  • Access
  • ESG
  • SpeakUp
Explore
  • Pipeline
  • Products
  • Clinical trials
  • Partnering
  • Events
Therapeutic areas
  • Cardiovascular, renal and metabolic
  • Immunology
  • Neuroscience
  • Oncology
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
Footer Bottom
© 2025 Novartis AG
  • Terms of use
  • Privacy
  • Cookie settings
  • Contacts
  • Locations
  • Site map
  • Open source
  • Web accessibility
Novartis Site Directory
This site is intended for a global audience